[
    [
        {
            "time": "",
            "original_text": "白雲山：擬以12億元增資王老吉大健康涼茶",
            "features": {
                "keywords": [
                    "白雲山",
                    "王老吉",
                    "增資",
                    "大健康",
                    "涼茶"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消費品",
                    "飲料"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山：擬以12億元增資王老吉大健康涼茶",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "白雲山擬12億增資王老吉 能為下半年業績添‘吉’利嗎？",
            "features": {
                "keywords": [
                    "白雲山",
                    "王老吉",
                    "下半年",
                    "業績",
                    "增資"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消費品",
                    "飲料"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白雲山擬12億增資王老吉 能為下半年業績添‘吉’利嗎？",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "「醫藥速讀社」康美藥業財務總監被重罰 王羽潇任春雨醫生新CEO 其他違規處罰",
            "features": {
                "keywords": [
                    "康美藥業",
                    "財務總監",
                    "違規",
                    "處罰",
                    "王羽潇",
                    "春雨醫生"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫療",
                    "製藥"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "「醫藥速讀社」康美藥業財務總監被重罰 王羽潇任春雨醫生新CEO 其他違規處罰",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 2,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "白雲山上半年營收同比增長125% 中報未提及金戈相關數據",
            "features": {
                "keywords": [
                    "白雲山",
                    "上半年",
                    "營收",
                    "增長",
                    "金戈"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "製藥",
                    "醫療"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白雲山上半年營收同比增長125% 中報未提及金戈相關數據",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "白雲山（600332.SH）：廣州國發擬減持不超1625.7909萬股 擬減持股份",
            "features": {
                "keywords": [
                    "白雲山",
                    "廣州國發",
                    "減持",
                    "股份"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "製藥",
                    "醫療"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "白雲山（600332.SH）：廣州國發擬減持不超1625.7909萬股 擬減持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "白雲山：股東廣州國發擬減持不超過1%股份 減持股份",
            "features": {
                "keywords": [
                    "白雲山",
                    "廣州國發",
                    "減持",
                    "股份"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "製藥",
                    "醫療"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "白雲山：股東廣州國發擬減持不超過1%股份 減持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "廣藥白雲山上半年營收增長125% ‘巨星品種’金戈繼續威猛",
            "features": {
                "keywords": [
                    "白雲山",
                    "上半年",
                    "營收",
                    "增長",
                    "金戈"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "製藥",
                    "醫療"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "廣藥白雲山上半年營收增長125% ‘巨星品種’金戈繼續威猛",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "白雲山2019年中報：營收333.41億元 ‘大商業’板塊撐起半邊天",
            "features": {
                "keywords": [
                    "白雲山",
                    "2019年",
                    "中報",
                    "營收",
                    "大商業"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "製藥",
                    "醫療"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白雲山2019年中報：營收333.41億元 ‘大商業’板塊撐起半邊天",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "【白雲山中報點評：公允價值變動影響利潤增速，王老吉盈利提升超預期—方正食品飲料190822】",
            "features": {
                "keywords": [
                    "白雲山",
                    "中報",
                    "公允價值",
                    "利潤增速",
                    "王老吉",
                    "盈利"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "消費品",
                    "飲料"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【白雲山中報點評：公允價值變動影響利潤增速，王老吉盈利提升超預期—方正食品飲料190822】",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "白雲山（00874-HK）中期少賺3%不派息 多途徑集資滿足資本性支出 盈利能力下降",
            "features": {
                "keywords": [
                    "白雲山",
                    "中期",
                    "盈利能力",
                    "下降",
                    "集資"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "製藥",
                    "醫療"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "白雲山（00874-HK）中期少賺3%不派息 多途徑集資滿足資本性支出 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]